Amy Schacterle - Nov 5, 2024 Form 3 Insider Report for Acumen Pharmaceuticals, Inc. (ABOS)

Role
Chief Regulatory Officer
Signature
/s/ Derek Meisner, Attorney-in-Fact
Stock symbol
ABOS
Transactions as of
Nov 5, 2024
Transactions value $
$0
Form type
3
Date filed
11/6/2024, 05:24 PM

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney